Deng Chaoyuan's new drama is set for Gao Leng Xueba to perform "I am single by my ability"

2022/03/0617:02:28 hotcomm 2675

Today, the campus sweet pet drama "I'm Single by My Ability", directed by Lin Yan and starring Deng Chaoyuan and Song Yiren, officially released the final trailer, announcing that it will be broadcast exclusively on Youku on October 17, 2020. Deng Chaoyuan's sculptural male god Gao is cool and cute, and he will stage a funny trip under the cutest height difference.

Deng Chaoyuan's new drama is set for Gao Leng Xueba to perform


In the play, Deng Chaoyuan plays Qin Shen, an unpopular professional in the sculpture department. Transformed from a cold-faced male god into a sugar-sprinkling master, showing full of boyfriend power. In the play, Qin Shen sometimes gallops on the basketball court, and sometimes sits quietly in the classroom to study sculpture. High appearance and perfectionism coexist, and every scene is exciting. In addition, Qin Shen also frequently appeared in golden sentences, which added a lot of laughs to the whole play.

Deng Chaoyuan's new drama is set for Gao Leng Xueba to perform

Deng Chaoyuan's sweet pet drama "Meet You in the Sea of ​​People", in which Deng Chaoyuan previously served as the male lead, was successfully completed last month and is expected to be broadcast exclusively on Youku. Deng Chaoyuan, who is constantly exploring and advancing on the road of acting, believes that this time in "I'm Single by My Ability", it will bring you more surprises.

.

hotcomm Category Latest News

Editor of Meike: Bi Luming A-shares are approaching, and the goodwill of listed companies has exploded again! On the evening of January 3, Zhongsheng Pharmaceutical (002317, SZ) announced that it is expected to lose 380 million to 450 million yuan in 2020, and make a profit of 3. - DayDayNews

Editor of Meike: Bi Luming A-shares are approaching, and the goodwill of listed companies has exploded again! On the evening of January 3, Zhongsheng Pharmaceutical (002317, SZ) announced that it is expected to lose 380 million to 450 million yuan in 2020, and make a profit of 3.

Breaking out on the weekend! The pharmaceutical company plans to raise the maximum amount of nearly 900 million goodwill impairment, with a maximum loss of 450 million. The stock price fell by 45% in less than half a year, and 34,000 shareholders were in a frustration.